Articles related to FDA

The FDA’s approval of brexpiprazole for Alzheimer’s-related agitation has sparked a debate over its efficacy and safety, raising concerns that extend beyond this specific drug to the integrity of the regulatory process itself.

The FDA approval of motixafortide in combination with filgrastim offers a new, evidence-based approach to improve stem cell mobilization in multiple myeloma patients undergoing ASCT.

The FDA’s recent approval of updated Pfizer-BioNTech and Moderna COVID-19 vaccines marks a significant step in adapting to current viral variants. Stay informed and prepare to update vaccination protocols accordingly.

Stay informed on the FDA’s new cybersecurity guidelines for medical devices, as they set the standard for compliance and patient data safety.

Unprecedented eye drop recalls have led to significant health risks, including four fatalities. Learn more to ensure that you guide your patients towards safer, FDA-approved alternatives.

Discover how Miebo, supported by phase 3 clinical trials, offers a unique approach to dry eye disease by specifically targeting tear evaporation.